Glenmark Finds Canadian Ryaltris Partner
Deal With Bausch Health Follows Russian And European Advances
Glenmark has struck the latest in a series of commercialization deals for its Ryaltris nasal spray in the form of a ten-year alliance with Bausch Health for the Canadian market.
